FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/10/058246 [Registered on: 04/10/2023] Trial Registered Prospectively
Last Modified On: 03/10/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A clinical trial to study the effects of Phalatrikadi kwath and Madhugrit in patients with Type 2 Diabetes Mellitus. 
Scientific Title of Study   A Comparative clinical study of Phalatrikadi kwath and Madhugrit in Madhumeha (Type 2 Diabetes Mellitus)  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR PARIDHI PAINULY 
Designation  Pg scholar 
Affiliation  Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan 
Address  Department of Kayachikitsa, OPD no. 13/14,Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan Haridwar Uttarakhand India.
Department of Kayachikitsa, OPD no. 13/14,Patanjali Ayurveda Hospital Haridwar Uttarakhand India.
Hardwar
UTTARANCHAL
249405
India 
Phone  8958757958  
Fax    
Email  paridhipainuly123@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ashwini Nilesh Ingle 
Designation  Associate professor 
Affiliation  Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan 
Address  Department of Kayachikitsa, OPD no. 13/14,Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan Haridwar Uttarakhand India.
Department of Kayachikitsa, OPD no. 13/14,Patanjali Ayurveda Hospital Haridwar Uttarakhand India.
Hardwar
UTTARANCHAL
249405
India 
Phone  919881165320  
Fax    
Email  dr.aningle2014@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Ashwini Nilesh Ingle 
Designation  Associate professor 
Affiliation  Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan 
Address  Department of Kayachikitsa, OPD no. 13/14,Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan Haridwar Uttarakhand India.
Department of Kayachikitsa, OPD no. 13/14,Patanjali Ayurveda Hospital Haridwar Uttarakhand India.
Hardwar
UTTARANCHAL
249405
India 
Phone  919881165320  
Fax    
Email  dr.aningle2014@gmail.com  
 
Source of Monetary or Material Support  
Patanjali Bhartiya Aryuvigyan evam Anusadhan Santhan  
 
Primary Sponsor  
Name  Patanjali Bhartiya Aryuvigyan evam Anusadhan Santhan 
Address  Patanjali Bhartiya Aryuvigyan evam Anusadhan Santhan, Haridwar-249405 Uttarakhand India  
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Paridhi Painuly  Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan   Department of Kayachikitsa, OPD no. 13/14, Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan ,Haridwar, 249405 Uttarakhand India
Hardwar
UTTARANCHAL 
8958757958

paridhipainuly123@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Patanjali Bhartiya Aryurvigyan Evam Anusandhan Sansthan Haridwar Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E119||Type 2 diabetes mellitus without complications. Ayurveda Condition: MADHUMEHAH/KSHAUDRAMEHAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Phalatrikadi kwath, Reference: ch.sa.chi.6/56, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 90 Days, anupAna/sahapAna: Yes(details: lukewarm water), Additional Information: -
2Comparator ArmDrugOther than Classical(1) Medicine Name: Madhugrit, Reference: NA, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/Tablets, Dose: 1100(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 90 Days, anupAna/sahapAna: Yes(details: lukewarm water), Additional Information: -
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1.Participants will be selected irrespective of gender and socio-economic status.
2.Patients aged between 30 – 65 years.
3.Participants fulfilling the signs and symptoms of Madhumeha.
a. Prabhutmutrata (Polyuria)
b. Kar-pada daha (Burning sensation in hands and feet)
c. Kantha taalusosha (polydipsia)
d. Availa mutrata (Turbid urine)
e. Angasaad (Fatigue)
f. Mukha Madhuryasyata (Sweet taste of mouth)
g. Daurgandhaya (Foul smell)
h. Blood glucose level
i. Fasting Blood glucose from 126mg/dl to 200 mg/dl
j. Post-Prandial Blood glucose from 200 mg/dl to 300 mg/dl
k. HBA1C > 6%
 
 
ExclusionCriteria 
Details  1. Patients with Type I Diabetes (Juvenile Diabetes)
2. Patients who are taking insulin.
3. Women with Gestational Diabetes.
4. Diabetes Mellitus with Hypertension, other endocrinological diseases and any other systemic disease.
5. Diabetes Mellitus with complications such as Retinopathy, Nephropathy and Diabetic foot
6. Pregnancy and lactating women. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Subjective parameters
1.Prabhoot-mutrata (Polyuria - frequency of urination)
2.Kanth taalu shosh (Polydipsia – the feeling of thirst)
3.Angsaad (Fatigue)
4.Avilmutrata (turbid urine)
5.Mukha – madhuryata (sweet taste of mouth)
6.Daurgandhaya (foul smell)
7.Karpada-daha (burning sensation in hand and feet)

Objective parameters
The objective assessment will be done on the basis of changes in the following
•Fasting Blood glucose
•Post-Prandial Blood glucose
•Lipid Profile
•Urine test for glucose


 
0 days, 30 days, 60 days, 90 days
HbA1c –
Time point - 0 days and 90 days



 
 
Secondary Outcome  
Outcome  TimePoints 
Objective parameters
The objective assessment will be done on the basis of changes in the following
1. Fasting Blood glucose
2. Post-Prandial Blood glucose
3. Lipid Profile
4. Urine test for glucose
 
0 days, 30 days, 60 days, 90 days

HbA1c –
Time point - 0 days & 90 days  
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   14/10/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is a Open Label, Double Arm  Comparative study, comparing the efficacy of Phalatrikadi kwath 40ml twice daily before meal and Madhugrit each 550mg 2 tablets twice daily after meal for 18 months in 40 patients with madhumeha roga that will be conducted in Opd no. 13/14 in Patanjali Ayurvedic Hospital, Haridwar. 
Close